• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma.

作者信息

Adams Hugo J A, Kwee Thomas C

机构信息

Department of Radiology and Nuclear Medicine, Deventer Ziekenhuis, Nico Bolkesteinlaan 75, 7416 SE, Deventer, The Netherlands.

Department of Radiology, Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

出版信息

Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1934-1936. doi: 10.1007/s00259-017-3771-8.

DOI:10.1007/s00259-017-3771-8
PMID:28707121
Abstract
摘要

相似文献

1
Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma.治疗结束时氟代脱氧葡萄糖正电子发射断层扫描（FDG-PET）在霍奇金淋巴瘤中的价值未经证实。
Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1934-1936. doi: 10.1007/s00259-017-3771-8.
2
Response to the letter by Adams and Kwee, entitled: "Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma".对亚当斯和奎所写题为《霍奇金淋巴瘤治疗结束时氟代脱氧葡萄糖正电子发射断层扫描的价值未经证实》的信件的回复。
Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1937-1939. doi: 10.1007/s00259-017-3773-6.
3
Hodgkin lymphoma: is there really a need for interim and end-of-treatment FDG-PET evaluations?霍奇金淋巴瘤：真的需要进行治疗中期和治疗结束时的氟代脱氧葡萄糖正电子发射断层显像（FDG-PET）评估吗？
Br J Haematol. 2018 Apr;181(1):122-123. doi: 10.1111/bjh.14495. Epub 2016 Dec 26.
4
Hodgkin lymphoma: is there really a need for interim and end-of-treatment FDG-PET evaluations? - Response to Adams & Kwee.霍奇金淋巴瘤：真的需要进行治疗中期和治疗结束时的氟代脱氧葡萄糖正电子发射断层显像（FDG-PET）评估吗？——对亚当斯和奎伊的回应
Br J Haematol. 2018 Apr;181(1):124-125. doi: 10.1111/bjh.14494. Epub 2017 Jan 20.
5
18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.18F-氟脱氧葡萄糖正电子发射断层扫描/磁共振成像在淋巴瘤中的应用：与18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的比较以及添加磁共振扩散加权成像的研究
Invest Radiol. 2016 Mar;51(3):163-9. doi: 10.1097/RLI.0000000000000218.
6
Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?霍奇金淋巴瘤：一线治疗后FDG PET/CT的诊断价值——是否仍需要对FDG摄取阳性病变进行活检？
Radiology. 2007 Jul;244(1):257-62. doi: 10.1148/radiol.2441060810.
7
Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma.中期氟代脱氧葡萄糖正电子发射断层扫描（FDG-PET）对于选择需要改变治疗方案的早期和晚期霍奇金淋巴瘤患者没有价值。
Br J Haematol. 2018 Oct;183(1):129-131. doi: 10.1111/bjh.14906. Epub 2017 Sep 14.
8
Advanced Hodgkin's lymphoma: End-of-treatment FDG-PET should be maintained.晚期霍奇金淋巴瘤：应保留治疗结束时的氟代脱氧葡萄糖正电子发射断层显像（FDG-PET）检查。
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1254-1257. doi: 10.1007/s00259-017-3714-4.
9
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.氟-18氟脱氧葡萄糖正电子发射断层扫描与镓-67闪烁扫描术在淋巴瘤评估中的比较
Cancer. 2002 Feb 15;94(4):879-88.
10
Is [(18)F]fluorodeoxyglucose positron emission tomography the ultimate tool for response and prognosis assessment?[18F]氟脱氧葡萄糖正电子发射断层扫描是用于反应和预后评估的终极工具吗？
Hematol Oncol Clin North Am. 2007 Oct;21(5):855-69. doi: 10.1016/j.hoc.2007.07.003.

引用本文的文献

1
Response to the letter by Adams and Kwee, entitled: "Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma".对亚当斯和奎所写题为《霍奇金淋巴瘤治疗结束时氟代脱氧葡萄糖正电子发射断层扫描的价值未经证实》的信件的回复。
Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1937-1939. doi: 10.1007/s00259-017-3773-6.

本文引用的文献

1
Advanced Hodgkin's lymphoma: End-of-treatment FDG-PET should be maintained.晚期霍奇金淋巴瘤：应保留治疗结束时的氟代脱氧葡萄糖正电子发射断层显像（FDG-PET）检查。
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1254-1257. doi: 10.1007/s00259-017-3714-4.
2
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.早期中期 PET 阳性的晚期霍奇金淋巴瘤患者单独接受 BEACOPP 或联合利妥昔单抗（HD18）治疗的无进展生存期：德国霍奇金研究组开展的一项开放标签、国际、随机 3 期研究。
Lancet Oncol. 2017 Apr;18(4):454-463. doi: 10.1016/S1470-2045(17)30103-1. Epub 2017 Feb 22.
3
Predictive Value of Interim [F]Fluorodeoxyglucose-Positron Emission Tomography in Advanced-Stage Hodgkin Lymphoma Is Not Well Established.中期[F]氟脱氧葡萄糖-正电子发射断层扫描在晚期霍奇金淋巴瘤中的预测价值尚未明确确立。
J Clin Oncol. 2017 Jan 20;35(3):370-371. doi: 10.1200/JCO.2016.68.1494. Epub 2016 Oct 28.
4
Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: Systematic review and meta-analysis.根据组织学确定的淋巴瘤治疗中期和治疗结束时氟代脱氧葡萄糖正电子发射断层扫描（FDG-PET）假阳性病变比例：系统评价和荟萃分析
Eur J Radiol. 2016 Nov;85(11):1963-1970. doi: 10.1016/j.ejrad.2016.08.011. Epub 2016 Aug 19.
5
Posttreatment PET/CT Rather Than Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma: A Prospective Study Comparing PET/CT with Conventional Imaging.使用迪厄多内标准的治疗后PET/CT而非中期PET/CT可预测儿童霍奇金淋巴瘤的预后：一项比较PET/CT与传统成像的前瞻性研究
J Nucl Med. 2017 Apr;58(4):577-583. doi: 10.2967/jnumed.116.176511. Epub 2016 Oct 6.
6
Hodgkin lymphoma: a negative interim-PET cannot circumvent the need for end-of-treatment-PET evaluation.霍奇金淋巴瘤：中期PET阴性并不能避免治疗结束时PET评估的必要性。
Br J Haematol. 2016 Nov;175(4):652-660. doi: 10.1111/bjh.14292. Epub 2016 Aug 19.
7
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.基于中期PET-CT扫描指导的晚期霍奇金淋巴瘤适应性治疗
N Engl J Med. 2016 Jun 23;374(25):2419-29. doi: 10.1056/NEJMoa1510093.
8
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.美国采用早期中期氟脱氧葡萄糖-正电子发射断层扫描成像对Ⅲ至Ⅳ期霍奇金淋巴瘤进行适应性治疗的多中心试验：西南肿瘤协作组S0816。
J Clin Oncol. 2016 Jun 10;34(17):2020-7. doi: 10.1200/JCO.2015.63.1119. Epub 2016 Apr 11.
9
Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.晚期霍奇金淋巴瘤中基于正电子发射断层扫描（PET）反应的临时治疗：HD0801 研究 II 期的最终结果。
J Clin Oncol. 2016 Apr 20;34(12):1376-85. doi: 10.1200/JCO.2015.63.0699. Epub 2016 Feb 16.
10
Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era.霍奇金淋巴瘤：澳大利亚在现代使用ABVD化疗的经验。
Ann Hematol. 2016 Apr;95(5):809-16. doi: 10.1007/s00277-016-2611-4. Epub 2016 Feb 15.